Intraarterial chemotherapy of liver metastases of colorectal cancer. Experience of National Cancer Institute of Ukraine. Risk of death at two years. Risk ratio 1.23, 95% CI (1.05,1.45), p-value 0.01.

Peritoneal carcinomatosis from colorectal cancer: Not a lost cause. Background: Y-90 radioembolization has shown promise in the treatment of unresectable metastatic colorectal cancer (mCRC) and ...

ABK Biomedical, Inc. announced the completion of patient enrollment in the ROUTE90 pivotal study evaluating the company’ ...

The approval was based on data from the LEGACY study, a single-arm, retrospective trial that evaluated treatment with TheraSphere Y90 glass microspheres in 162 patients with unresectable ...

Hackensack Meridian Health Riverview Medical Center is pleased to announce that it now offers Y-90 radioembolization, an innovative and minimally invasive method to treat liver tumors without surgery.

Finding innovative, minimally invasive ways to treat liver cancer—and being able to tailor that treatment individually to patients—are hallmarks of interventional radiologists. Advances in yttrium-90 ...

Hackensack Meridian Health Bayshore Medical Center now offers Y-90 radioembolization, an advanced and minimally invasive method to treat liver tumors without surgery. This procedure is used to treat ...

MARLBOROUGH, Mass., March 18, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval of the TheraSphere™ Y-90 Glass ...

Radiation segmentectomy, a minimally invasive procedure that can be done on an outpatient, same-day basis, is potentially as curative as other curative strategies for early-stage hepatocellular ...